Also on Friday, Deutsche Bank cut its price target to $295 from $305, citing "considerable uncertainty" related to the outbreak.
Apple's second-quarter results are expected to be released around the end of next month. Currently, Wall Street expects adjusted earnings of about $2.71 a share and revenue of $61.5 billion. The consensus for earnings has dropped 9.6% over the past month, according to data compiled by Bloomberg, while the revenue view is down 5.5% over the same period.
UBS on Friday wrote that "the risk of lower demand in the near-term is increasing" for Apple, and that the impact was "likely to expand beyond China." Analyst Timothy Arcuri added that while he had expected some demand would simply be delayed, "given the broader impact, we now think the demand impact could continue" into June.
The firm has a buy rating and $355 price target, but it is "cautious in the near-term -- particularly on the demand side if the U.S. suddenly goes into a multi-[quarter] recession."
On a more positive note, Nomura Instinet analyst Jeffrey Kvaal stood by his recent comments that Apple's supply chain was seeing a faster recovery than he expected. The "risk of a major supply shock is declining," he wrote. Supply constraints "seem likely to be short term in nature."
Relative to supply constraints, he added, "we hope and expect that potential demand declines are less severe."
- Bloomberg